This topic contains a solution. Click here to go to the answer

Author Question: A government financed program that requires potential recipients to show that they are poor in order ... (Read 72 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
A government financed program that requires potential recipients to show that they are poor in order to claim benefits.
 
  a) Unemployment insurance b) Public assistance
  c) Social insurance
  d) Pension insurance

Question 2

The type of insurance that the federal government uses to compel individuals or their employers to purchase to protect against the possibility of indigency.
 
  a) Security
  b) Public
  c) Social
  d) Pension



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katkat_flores

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Aug 4, 2018
Excellent


bassamabas

  • Member
  • Posts: 294
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

After a vasectomy, it takes about 12 ejaculations to clear out sperm that were already beyond the blocked area.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library